Search results
The True Obesity Paradox: Obese and Malnourished?
Author(s):
Mohammed El-Sheikh
,
Nora Olsen El Caidi
,
Aginsha Kandiah
,
et al
Added:
1 year ago
Original Research
Author(s):
Barbara McGowan
Added:
2 years ago
ECO 2024 — Prof Barbara McGowan (Guy's and St Thomas' Hospital & King's College, UK) joins us to discuss the findings from the STEP 10 trial (NCT05040971, Novo Nordisk).This Phase 3 randomised clinical trial investigated the efficacy and safety of subcutaneous semaglutide 2.4 mg (GLP-1 RA) in 181 participants with obesity (BMI greater than or equal to 30.0 kg/m^2) and prediabetes. The primary…
View more
Added:
10 months ago
Source:
Radcliffe CVRM
A secondary analysis of the SUMMIT trial has found that the benefits of tirzepatide on reducing the risk of cardiovascular death or worsening heart failure (HF) are consistent across all levels of obesity in patients with heart failure with preserved ejection fraction (HFpEF).¹ However, patients with a higher baseline body mass index (BMI) experienced greater improvements in exercise capacity and…
View more
Added:
6 months ago
Source:
Radcliffe Cardiology
Natriuretic peptides are key biomarkers used to risk-stratify patients with heart failure (HF), but current guideline thresholds do not typically account for body mass index (BMI).¹ A new pooled analysis suggests that these fixed thresholds may underestimate risk in patients with HF and higher BMI, questioning the one-size-fits-all approach.²This study was a participant-level pooled analysis of…
View more
Author(s):
Mohammed El-Sheikh
,
Nora Olsen El Caidi
,
Aginsha Kandiah
,
et al
Added:
7 months ago
Added:
4 months ago
Source:
Radcliffe Cardiology
While social determinants of health (SDOH) are known to influence outcomes in acquired cardiovascular diseases, their impact on conditions with a strong genetic basis, such as hypertrophic cardiomyopathy (HCM), has been less clear.² A new study using data from the Sarcomeric Human Cardiomyopathy Registry (SHaRe) suggests that area-based social factors are independently associated with adverse…
View more
Obesity Definitions and LOS in Heart Failure
Author(s):
Michał Czapla
,
Christopher S Lee
,
Maria Jędrzejczyk
,
et al
Added:
2 weeks ago
Original Research
Obesity, Cardiac MRI Structure and Non-ischaemic Cardiomyopathy
Author(s):
Long Peng
,
Tao Zeng
,
Enxi Quan
,
et al
Added:
1 year ago
Original Research
Quality of Life After AVR
Author(s):
Meng He
,
Jinwei Zhang
,
Jianbo Yu
,
et al
Added:
1 year ago
Original Research
Effects of GLP-1 Receptor Agonists in Heart Failure Patients
Author(s):
Anastasia Shchendrygina
,
Amina Rakisheva
,
Ilya Giverts
,
et al
Added:
1 year ago
Review Article
